Biomira Inc. has filed for a public offering of about 4 millionshares of common stock. The Canadian company, which isdeveloping cancer diagnostics and therapeutics, would have17.4 million shares outstanding after the offering.

Canadian underwriters will be ScotiaMcLeod Inc., Burns FryLtd. and Richardson Greenshields of Canada Ltd. In the UnitedStates, the offering will be led by ScotiaMcLeod (U.S.A.) Inc.There is no overallotment option.

Altamira Capital Corp., which holds 14.5 percent of Biomirashares, and Bioalta Inc., which holds 26.6 percent, havecommitted to subscribe for sufficient shares to maintain their40 percent aggregate interest in the Edmonton, Alberta,company.

Biomira markets four in vitro diagnostic kits forgastrointestinal, ovarian and breast cancer. The company'sstock trades on the Toronto, Montreal and Alberta exchangesunder the symbol "BRA." Biomira has applied to begin trading onNASDAQ under the symbol "BIOM."

(c) 1997 American Health Consultants. All rights reserved.